Evidence map›Paper›PMID 37525052›Full record

ArticleAdvances in experimental medicine and biology2023

Effective Preprocessing of Single-Cell RNA-Seq for Unravelling Alzheimer's Disease Signatures.

Apollon Zoiros, Aristidis Vrahatis

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Apollon ZoirosInterdisciplinary PSP Bioinformatics and Neuroinformatics (BNP), School of Science and Technology, Hellenic Open University, Patras, Greece.
Aristidis VrahatisBioinformatics and Human Electrophysiology Lab (BiHELab), Department of Informatics, Ionian University, Corfu, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development in the field of biomedical technology has brought significant progress in the diagnosis and prediction of many complex diseases. Part of this development is the single-cell RNA sequencing analysis, which allows the study of a complex disease in great depth at the cellular level. Such analyses can decipher the mechanisms that cause complex diseases, such as Alzheimer's disease (AD). However, the increasing depth in the collection of single-cell RNA sequencing data implies, in addition to greater challenges, the production of a large amount of information, which needs careful analysis. Toward this direction, we examine the approach to single-cell RNA sequencing data through the development of an exploratory data analysis methodology. For this purpose, a combination of various tools is presented for their effective and efficient processing. At the same time, reference is made to the relevant biological concepts, the goals and challenges of the studies, and the workflows of sequencing, preprocessing, and analysis of the data. Our framework is applied to Alzheimer's disease data providing evidence that such data are quite complex while the appropriate preprocess step can boost the machine learning processes for identifying AD signatures.

Indexed as

Alzheimer DiseaseHumansSequence AnalysisSingle-Cell Gene Expression AnalysisAlzheimer’s diseaseExploratory data analysisSingle-cell RNA sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.